AACR Hosts Successful 102nd Annual Meeting in Orlando
PHILADELPHIA — More than 16,000 people from 67 countries around the world, including Japan, attended the American Association for Cancer Research’s 102nd Annual Meeting, held in Orlando, Fla., April 2-6, 2011.
“We were excited to host our Annual Meeting in Orlando, a destination for the AACR’s main event where we were able to showcase cancer research advances that are benefitting cancer patients everywhere,” said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR.
The economic impact of the Annual Meeting on Orlando, Fla., and the surrounding area was approximately $32.9 million. This figure includes the costs of hotels and lodging, food and beverage, the convention center and other related expenses.
“We were pleased to exceed our housing commitments with all of our hotel partners,” said Linda M. Still, CMP, Director of Meetings and Exhibits. “Feedback from attendees was very positive. They enjoyed the conference venue, as well as spending free time at the many excellent local restaurants and entertainment facilities.”
At the AACR 102nd Annual Meeting 2011, participants presented and discussed research in a variety of formats that stimulated significant discussion of the field, i.e., plenary lectures, symposia, minisymposia, workshops, poster sessions and other types of sessions.
The AACR’s Annual Meeting attracts leading academic, industry, philanthropic and government laboratory and clinical scientists, as well as students, cancer survivors, patient advocates and other health care professionals. This year, more than 6,000 scientific proffered papers were presented, complementing an outstanding program of invited scientific and educational events.
The AACR’s 103rd Annual Meeting 2012 will be held in Chicago, Ill., from March 31 to April 4.
# # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.